@TAMuscDis

A gold open access peer-reviewed journal publishing high-quality articles across all areas of rheumatology, osteoporosis and related disciplines. IF=4.2

 London
journals.sagepub.com/home/tab
Joined July 2020
  • Tweets216
  • Following164
  • Followers342
22Media
Thank you for such a thought-provoking and comprehensive congress #EULAR2024! See you next year in Barcelona
1
88
An interesting late-breaking abstract from our Editor-in-Chief @DrPoddubnyy on the last day of #EULAR2024 presenting a novel study design to test treat-to-target for patient's with #AxialSpondyloarthritis
3
103
Looking forward to #EULAR2024 Day 3!
2
63
Fantastic talk from Prof. Neil Basu at #EULAR2024 this morning on how partitioning musculoskeletal conditions into distinct pain mechanisms is not the most effective way to treat a patient's pain
1
3
104
Exciting new research on pre-diagnostic proteomic biomarkers for #Gout and predictive biomarkers for treatment response in #RheumatoidArthritis (and more!) presented at the first abstract session of #EULAR2024 yesterday! Co-moderated by our Associate Editor @ChristianDejaco
1
39
A great first day at #EULAR2024. Especially @Lupusreference's engaging and accessible talk about what's on the horizon for #Lupus.
2
71
Using natural language processing to explore characteristics and management of patients with SpA (axSpA and PsA) in Spain. Check it out here: journals.sagepub.com/doi/10.… @DiegoBenavent

Using natural language processing to explore characteristics and management of patients with axial...

Background: Spondyloarthritis (SpA) is a group of related but phenotypically distinct inflammatory disorders that include axial SpA (axSpA) and psoriatic arthri...

journals.sagepub.com
1
6
211
Introducing our NEW Special Collection on Artificial Intelligence in Rheumatology! 📢 Open for submissions! Share your insights with us! 📝👩‍💻 #AI #Rheumatology @DiegoBenavent @vincevenerito @xabiermich
6
1
19
1,899
A new Special Collections is underway! Psoriatic arthritis: Clinical, Diagnostic, and Therapeutic Aspects. Guest Editors: @FragoulisGeorge @SteZhao Find out more here: journals.sagepub.com/page/ta…

Sage Journals: Discover world-class research

Subscription and open access journals from Sage, the world's leading independent academic publisher.

journals.sagepub.com
1
1
435
Therapeutic Advances in Musculoskeletal Disease retweeted
Lilly Medical US
@LillyMedical22 Sep 2023
Now published in @TAMuscDis: The effect of an IL-17A inhibitor on axial manifestations in patients with psoriatic arthritis from two Phase III clinical studies, SPIRIT-P1 and SPIRIT-P2. #PsA #psoriaticarthritis Click here to access the full article: e.lilly/469DQko
1
2
13
139,978
How can we improve outcomes for PsA patients? Read more for the HIPPOCRATES programme. journals.sagepub.com/doi/10.… @StefanSiebert1

Application of clinical and molecular profiling data to improve patient outcomes in psoriatic...

Achieving a good outcome for a person with Psoriatic Arthritis (PsA) is made difficult by late diagnosis, heterogenous clinical disease expression and in many c...

journals.sagepub.com
2
3
1,337
Ixekizumab is effective in patients with Axial-PsA. Results from two phase III trials. journals.sagepub.com/doi/ful… @DrPoddubnyy

The effect of ixekizumab on axial manifestations in patients with psoriatic arthritis from two...

Background: Psoriatic arthritis (PsA) is a chronic inflammatory condition predominantly affecting the peripheral joints. However, some patients with PsA can exp...

journals.sagepub.com
1
2
328
New study shows Abatacept remains effective & safe in RA patients with previous malignancy, challenging previous inconsistent reports. 🩺🔬 #RheumatoidArthritis #MedicalResearch #abatacept Check this out! bit.ly/3OH8WJd
1
190
Therapeutic Advances in Musculoskeletal Disease retweeted
Therapeutic Advances in Rare Disease@TARareDisease31 May 2023
We are celebrating today as Therapeutic Advances in Rare Disease is now indexed in PubMed & Scopus! A great milestone for the Journal! Congratulations @Urvalind @maurizioscarpa @BCH_Rare @JemimaMellerio @votrubam @MariyaMoosajee @oligogirl @roon_mom @DrJohnBladen @SageJournals
1
5
146
🔬 Excited to be part of #EULAR2023! We've curated a special collection of articles just for this conference. Share knowledge, foster connections, spark dialogues. Let's change the future together! 📷#Rheumatology #OpenAccess @SageClinMed ➡️bit.ly/3ovhb1W
2
5
331
Therapeutic Advances in Musculoskeletal Disease retweeted
Alina DIMA@drALINAdima26 May 2023
10000 views reached !!! 🎉🎉🎉🎉🎉 Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge @TAMuscDis Dima Alina, Jurcut Ciprian, Chasset Francois, Felten Renaud, Arnaud Laurent journals.sagepub.com/doi/ful… – at Bucharest, Romania
3
13
1,148
Therapeutic Advances in Musculoskeletal Disease retweeted
Therapeutic Advances in Chronic Disease@TAChronicDis22 May 2023
New article online! Risk factors for the long-term incidence and progression of knee osteoarthritis in older adults: role of nonsurgical injury bit.ly/3WFgeRj @SageClinMed @TAMuscDis #OpenAccess #Osteoarthritis #KneeOsteoarthritis #TASeries #RheumTwitter
1
3
134
Any use of DMARDs in hand OA? Check out this updated review published in TAMD journals.sagepub.com/doi/ful…

An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand...

Osteoarthritis (OA) is a highly prevalent condition worldwide associated with pain, progressive disability, reduced participation in social activities, and impa...

journals.sagepub.com
1
86
🔬 Years of research, still no effective disease-modifying #osteoarthritis drugs (DMOADs) 💊. #MRI could be the key to success in future DMOAD trials. @ali_guermazi @FrankRoemer1 Michel D. Crema, Mohamed Jarraya, Ali Mobasheri, Daichi Hayashi Read more ➡️bit.ly/3N3Y8pl
160
📢 New review highlights the urgent need for more effective treatments for hand #osteoarthritis. 🦴💊 From Sara Tenti, @olibruyere, Sara Cheleschi, Jean-Yves Reginster, @ilmannato, Antonella Fioravanti bit.ly/3L4jvFe
2
135
Load more